IPCALAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > ipcalab

Technical Analysis

Technical Strength: 5.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 56.6. According to RSI analysis, ipcalab is strong. 7.0 IPCALAB RSI Chart
MACD (?) MACD: 4.35 and Signal Line: 6.81. According to MACD analysis, ipcalab is marginally weak. 3.0 IPCALAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, ipcalab is facing resistance from it's 20-day simple moving average at 586.73 and support level is at 560. 3.0 IPCALAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, ipcalab is in a strong uptrend. Major support levels are 577.2848, 561.0188, 530.6675. 10.0 IPCALAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.455. 5.0 IPCALAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 579.6948 and 565.7. Resistance level is 625.0. 6.5 IPCALAB Fibonacci Retracement Chart
Average True Range (?) ATR: 18.5 NA IPCALAB Average True Range Chart
Average Directional Index (?) ADX is 26.3 which means IPCALAB is in a trend. NA IPCALAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 18, 2018
Open Price 585.35
High Price 588.0
Low Price 575.0
Close Price 584.75
Absolute Change 0.75
Percentage Change 0.128%
Weekly Change 2.17%
Monthly Change 1.86%
Yearly Change 6.49%
52-week high 657.6
52-week low 400.0
Corporate Actions
ExDate Purpose
July 27, 2017 AGM/DIV -RE 1 PER SHARE
July 22, 2015 AGM/DIV-RE 1 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.388
Confidence in Beta0.676%
Market Capital Rs. 7378.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 7.25
TTM Price-to-Earnings (P/E) Ratio 80.7
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 18 January 2018: Deliverable Quantity:5.74e+04 NA IPCALAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 18 January 2018: Daily Volatility:0.3019 NA IPCALAB Annualized Daily Volatility (Spot Price) Chart


January 17, 2018 IPCAcquisitionCA Laboratories Limited has informed the Exchange regarding" Acquisition of 100% share capital of Pisgah Labs Inc. North Carolina. USA by Company's subsidiaries".
November 16, 2017 IPCUpdatesCA Laboratories Limited has informed the Exchange regarding 'Half yearly certificate under Regulation 52(5) of the SEBI (LODR) Regulations, 2015, for Debt Securities'.
See all Announcements

Board Meetings

Date Meeting Date Purpose
November 01, 2017 November 14, 2017 intResultster-alia, to consider and take on record the Unaudited Financial Results for the 2nd quarter and half year ended September 30, 2017 of the financial year 2017-18.
July 27, 2017 August 11, 2017 IntResultster-alia, to take on record the Unaudited Financial Results for the 1st Quarter ended June 30, 2017 of the financial year 2017-18.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 564.2 Rs. 569.6 Rs. 577.2 Rs. 582.6 Rs. 590.2 Rs. 595.6 Rs. 603.2